Although the prevalence of ovarian cancer is fairly low, it is often asymptomatic until after metastasis, resulting in it being the fourth leading cause of cancer death in females in the USA. The development of biomarker screening tests for ovarian cancer has been challenging and the situation is still not satisfactory. Additionally, the tests that […]
By Dr Reinhold Wimberger-Friedl Analysis of tumour tissue for molecular biomarkers is a labour-intensive and time-consuming process, requiring precision at each of the many steps involved. This article discusses how recently launched technology is helping to improve sample selection and tissue dissection.
By Rosa Ferrer, Andrea Mansilla and Maria Costa The role of human chorionic gonadotropin in pregnancy has been extensively studied for many years. However, the importance of this hormone goes beyond pregnancy. It can also be used as a biomarker, mainly in trophoblastic tumours, but as will be shown later in this article, its importance […]
Attend the Innovation Days in Biology (JIB) and stay connected to the scientific, technical, professional and organizational developments of medical biology. Medical biology is essential to the health of our fellow citizens, from diagnosis to treatment and follow-up, scientists are continually looking for innovation. There are many hot topics expected at the event in Paris […]
Cancer and coronary diseases, infections and new anti-bacterial active substances, digitalisation and artificial intelligence – these are some of the top issues to be discussed this year at the MEDICA LABMED FORUM, which is part of the MEDICA 2023 trade fair in Düsseldorf, Germany.
What advances mean for modern laboratories, and why continued innovation is imperative by Dr Gina Zini
The subtyping of bladder cancers is a complicated business. It is, however, necessary as it has important implications for prognosis and therapeutic decisions. CLI caught up with Asst. Prof. Chelsea L. Jackson (University of Manitoba, Winnipeg, MB, Canada) and Prof. David Berman (Queen’s University, Kingston, ON, Canada) to find out more about how the current […]
Bronchoalveolar lavage is an effective way of collecting samples of cells and molecules from the alveoli of the lungs, the analysis of which may allow proteomic determination of signatures of disease states and so aid diagnosis. Such analysis has, however, been hampered by a number of factors. CLI caught up with Professors Griffin and Wendt […]
Researchers from the United Kingdom hope that a new, publicly available database they have created will shrink, not grow, over time. That’s because it is a compendium of the thousands of understudied proteins encoded by genes in the human genome, whose existence is known but whose functions are mostly not.
Researchers from the Organoid group (Hubrecht Institute, Utrecht University)) and the Princess Máxima Center (Utrecht, The Netherlands) have taken steps to advance cancer tumour models by using base editors to simultaneously introduce multiple cancer-related mutations into healthy organoids. They thereby succeeded in efficiently making tumour organoids that model liver, colorectal and endometrial cancer. The results […]
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.